Alector ALEC

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.07 (-4.43%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Alector (ALEC)
    Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $1.44

    • Market Cap

      $142.68 Million

    • Price-Earnings Ratio

      -1.17

    • Total Outstanding Shares

      99.09 Million Shares

    • Total Employees

      238

    • Dividend

      No dividend

    • IPO Date

      February 7, 2019

    • SIC Description

      Biological Products, (no Disgnostic Substances)

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      131 oyster point blvd., suite 600, South san francisco, CA, 94080

    • Homepage

      https://www.alector.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Cash Flow, Continuing$-41.23 Million
    Net Cash Flow From Investing Activities$107.13 Million
    Net Cash Flow From Financing Activities$81.54 Million
    Net Cash Flow From Operating Activities, Continuing$-229.91 Million
    Net Cash Flow From Investing Activities, Continuing$107.13 Million
    Net Cash Flow$-41.23 Million

    Income Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Income/Loss Available To Common Stockholders, Basic$-119.05 Million
    Depreciation and Amortization$5.41 Million
    Costs And Expenses$219.50 Million
    Diluted Average Shares$96.59 Million
    Net Income/Loss Attributable To Parent$-119.05 Million
    Basic Average Shares$96.59 Million

    Comprehensive Income

    January 1, 2024 to December 31, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss$-118.97 Million
    Other Comprehensive Income/Loss$77,000
    Other Comprehensive Income/Loss Attributable To Parent$77,000
    Comprehensive Income/Loss Attributable To Parent$-118.97 Million

    Balance Sheet

    January 1, 2024 to December 31, 2024
    MetricValue
    Liabilities$341.50 Million
    Noncurrent Assets$43.49 Million
    Liabilities And Equity$468.30 Million
    Long-term Debt$10 Million
    Assets$468.30 Million
    Current Assets$424.82 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ALEC from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.